Advertisement
Loading...

Liquidia Corporation

LQDA•NASDAQ
Healthcare
Biotechnology
$56.45
$-1.14(-1.98%)
U.S. Market is Open • 10:36

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio235.08
EPS (TTM)$0.17
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$33.83
3 Months$43.76
1 Year Target$49.34

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 87.42, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $49.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 235.08 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.97%
5-Day Change
41.06%
1-Month Change
53.19%
3-Month Change
55.24%
6-Month Change
111.48%
Year-to-Date (YTD) Change
71.93%
1-Year Change
217.96%
3-Year Change
701.35%
5-Year Change
2080.15%
All-Time (Max) Change
434.23%

Contact Information

https://www.liquidia.com
919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions